相关实验视频
Updated: Feb 15, 2026

11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.7K
在儿科皮肤病学中的单体缩症
1European University, Department of Dermatology, Tbilisi; "Kanveni" - National Center of Dermatology and Venereology, Georgia.
Georgian medical news
|February 13, 2026
概括
儿科指甲疾病,通常呈现为多个指甲问题,通常会影响指甲,并且有良好的预后. 像形虫病和博氏线这样的疾病是自我限制的,而感染需要治疗潜在原因.
科学领域:
- 儿科皮肤病学 儿科皮肤病学
- 爪子疾病 爪子疾病
- 单体变症是一种单体变症.
背景情况:
- 儿科指甲疾病与成人病例不同,包括感染和炎症过程.
- 儿童的指甲疾病可以表明潜在的综合征或系统性疾病.
- 阴发病可能是之前感染的后果.
研究的目的:
- 鉴定儿童获得性阴发育不良的原因,临床过程和特征.
- 描述儿科指甲病理学的谱.
主要方法:
- 在皮肤病中心对47名儿科患者 (3-12岁) 的数据进行分析.
- 通过显微镜和文化检查进行病因鉴定.
- 数字皮肤镜用于全面评估指甲结构变化.
主要成果:
- 常见的诊断包括阴 (31.9%),阴 (23.4%) 和阴 (19.1%).
- 在70.2%的病例中观察到多重指甲疾病,主要影响指甲 (66%).
- 同时还发现了阴茎瘤和Beau的线条,一些病例显示指甲和脚的结合性涉.
结论:
- 儿科骨髓缩症主要与矩阵有关,通常表现为多种,主要是指甲,具有良性过程的疾病.
- 手,脚,口病的晚期并发症,如乳腺炎和Beau的线条,是自我限制的.
- 感染相关的指甲疾病在治疗潜在病理时具有有利的预后.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
279
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism
251
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
251
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
316
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
316

